Search

Stradling

Stellar Biotechnologies Completes Reverse Merger Into a Public Entity

Stellar Biotechnologies, Inc.

Represented Stellar Biotechnologies, Inc. in its reverse merger into a public entity transaction on the TSX Venture Exchange.

Stellar Biotechnologies, Inc. is the world leader in sustainable manufacture of KLH, an important immune-stimulating protein used in wide-ranging therapeutic and diagnostic markets.